These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion. Damm AS; Reyer F; Langhoff L; Lin YP; Falcone FH; Kraiczy P Front Immunol; 2024; 15():1390468. PubMed ID: 38726006 [TBL] [Abstract][Full Text] [Related]
5. Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes. Xie J; Zhi H; Garrigues RJ; Keightley A; Garcia BL; Skare JT PLoS Pathog; 2019 Mar; 15(3):e1007659. PubMed ID: 30897158 [TBL] [Abstract][Full Text] [Related]
6. A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes. Garrigues RJ; Powell-Pierce AD; Hammel M; Skare JT; Garcia BL J Immunol; 2021 Dec; 207(11):2856-2867. PubMed ID: 34759015 [TBL] [Abstract][Full Text] [Related]
7. Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex. Garcia BL; Zhi H; Wager B; Höök M; Skare JT PLoS Pathog; 2016 Jan; 12(1):e1005404. PubMed ID: 26808924 [TBL] [Abstract][Full Text] [Related]
8. Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Stone BL; Brissette CA Front Immunol; 2017; 8():12. PubMed ID: 28154563 [TBL] [Abstract][Full Text] [Related]
9. The molecular determinants of classical pathway complement inhibition by OspEF-related proteins of Borrelia burgdorferi. Thomas S; Schulz AM; Leong JM; Zeczycki TN; Garcia BL J Biol Chem; 2024 May; 300(5):107236. PubMed ID: 38552741 [TBL] [Abstract][Full Text] [Related]
10. The relapsing fever spirochete Borrelia miyamotoi resists complement-mediated killing by human serum. Teegler A; Herzberger P; Margos G; Fingerle V; Kraiczy P Ticks Tick Borne Dis; 2014 Oct; 5(6):898-901. PubMed ID: 25104575 [TBL] [Abstract][Full Text] [Related]
11. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing. Pereira MJ; Wager B; Garrigues RJ; Gerlach E; Quinn JD; Dowdell AS; Osburne MS; Zückert WR; Kraiczy P; Garcia BL; Leong JM Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2117770119. PubMed ID: 35312359 [TBL] [Abstract][Full Text] [Related]
12. There Is a Method to the Madness: Strategies to Study Host Complement Evasion by Lyme Disease and Relapsing Fever Spirochetes. Marcinkiewicz AL; Kraiczy P; Lin YP Front Microbiol; 2017; 8():328. PubMed ID: 28303129 [TBL] [Abstract][Full Text] [Related]
13. The Complement Binding and Inhibitory Protein CbiA of Nguyen NTT; Röttgerding F; Devraj G; Lin YP; Koenigs A; Kraiczy P Front Cell Infect Microbiol; 2018; 8():23. PubMed ID: 29456970 [TBL] [Abstract][Full Text] [Related]